Labshake search
Citations for R&D Systems :
1 - 50 of 5455 citations for Mono 3 Carboxypropyl Phthalate 100 Ug Ml In Mtbe Ring 1 2 13C2 Dicarboxyl 13C2 99% since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Bioengineering 2023Quote: ... or 100 ug/mL NRP-1 Antibody (R&D Systems) every other day for 5 days.
-
bioRxiv - Microbiology 2023Quote: ... or 3 ug/ml of an anti-Dectin-1 antibody (MAB1859; R&D Systems). Mouse IgG was used as a control ...
-
bioRxiv - Bioengineering 2020Quote: ... STRO-1 (1:100, animal poly- or mono-, R&D System, Inc., Minneapolis, MN, USA) and the extracellular markers anti-integrin β1 (1:50 ...
-
bioRxiv - Microbiology 2022Quote: ... and 2 ug/mL of MetAP enzyme (R&D Systems 3537-ZN). Product detection,each reaction well is supplemented with 25 uL of 2 ng/mL DPPIV/CD26 (serine exopeptidase diluted in activation buffer).
-
bioRxiv - Cell Biology 2021Quote: ... CTSD (1 ug/mL, R&D Systems cat. no. AF1014), β-actin (1:1000 ...
-
bioRxiv - Cancer Biology 2021Quote: ... and 100 U/mL rmIL-2 (402-ML-100, R&D Systems) in the presence of increasing concentrations of SU11652 (sc-204310 ...
-
bioRxiv - Cancer Biology 2022Quote: ... The following neutralizing antibodies were used: anti-CXCL12 (R&D systems, clone 79014, 100 ug/ml) and anti-CXCL2 (Thermo Fisher ...
-
bioRxiv - Neuroscience 2024Quote: ... agrin (R&D Systems; 0.1 ug/mL) was added (Sup ...
-
bioRxiv - Cell Biology 2023Quote: ... supplemented with FGF2 (4 ug/mL; Biochemistry Department, University of Cambridge) and TGF-β1 (1.74 ug/mL; R&D Systems) using Vitronectin XF (STEMCELL Technologies ...
-
bioRxiv - Cancer Biology 2020Quote: ... and IL-2 (100 U/ml; R&D Systems) at 37°C and 5% CO2 ...
-
bioRxiv - Neuroscience 2021Quote: ... Capture antibody (R&D Systems, BAF1729, 0.25 ug/ml) was applied at RT for 1 hour ...
-
bioRxiv - Immunology 2023Quote: ... 2 ng/mL of IL-2 and 3 ng/mL of TGFβ (R&D systems, 7666-MB-055)) conditions ...
-
bioRxiv - Immunology 2020Quote: ... Cultures were supplemented 2 days later with 1.25 ml of R15 containing 100 U/ml recombinant human IL-2 (R&D systems; R15-100). R15-100 was added every 2 to 3 days thereafter ...
-
bioRxiv - Developmental Biology 2023Quote: ... VEGFR-3 (AF349, R&D Systems, 1:100, RRID:AB_355314), Coup-TF2 (EPR18443 ...
-
bioRxiv - Neuroscience 2020Quote: ... Primary antibodies used for immunoblotting were sheep anti-DRAXIN (AF6149, R&D systems, 1 ug/mL), goat anti-β-ACTIN (AB0145-200 ...
-
bioRxiv - Immunology 2021Quote: ... 100 IU/ml recombinant human IL-2 (R&D Systems), and 50 μM beta-mercaptoethanol (Fisher) ...
-
bioRxiv - Bioengineering 2022Quote: ... IgG1 antibody control (30 ug/mL, R&D Systems, MAB002), ICAM-1/CD54 (10ug/mL ...
-
bioRxiv - Neuroscience 2023Quote: ... Sigma P4957)/laminin (10 ug/mL, R&D Systems 3400-010-02) and subsequent manual rosette selection and expansion ...
-
bioRxiv - Bioengineering 2024Quote: ... 3 µm CHIR99021 (Stemgent) and 100 ng/ml SHH (R&D Systems) for 5 days ...
-
bioRxiv - Neuroscience 2022Quote: ... DIV12 hippocampal neurons were treated with either 2 ug/mL of recombinant Nptx2 (CF 7816-NP-050, R&D Systems) or BSA as control ...
-
bioRxiv - Physiology 2022Quote: ... rhuIL-3 (1 ng/ml, R&D Systems). Erythropoiesis was induced by addition of 3 U/ml recombinant human erythropoietin (rEPO ...
-
bioRxiv - Molecular Biology 2022Quote: ... iPSC at 60-70% confluence were treated for 3 days with 100 ng/mL Activin A and 100 ng/mL bFGF (R&D Systems) in the presence of increasing levels of FBS (0% on day 1 ...
-
bioRxiv - Bioengineering 2019Quote: Stage 1: 3 days in S1 basal media with 100 ng/ml Activin A (R&D Systems; 338-AC) and 3 μM CHIR99021 (Stemgent ...
-
bioRxiv - Immunology 2022Quote: ... 1% PS and 100 IU/ml of human recombinant IL-2 (R&D Systems, 202-IL-050). Cells were used at low passage numbers ...
-
bioRxiv - Immunology 2024Quote: ... and 100 U/ml IL-2 (R&D Systems, Minneapolis, MN). NK-92 cells were passaged in 2–3 day interval to maintain the cell density at 2.5 × 105 – 1 × 106 cells/ml ...
-
bioRxiv - Cell Biology 2023Quote: ... anti-Galectin-3 (1:50; R&D systems, AF1197 & 1:100; Biolegend, 125401), anti-Hsp70 (1:300 ...
-
bioRxiv - Developmental Biology 2019Quote: ... and 100 ng/ml CHO-derived mouse R-spondin 1 or 5 ng/ml CHO-derived mouse R-spondin 2 (R&D System). The final concentration of Rspondins in the culture medium was initially tested in pilot experiments in order to add comparable amounts of bioactive ligands (bioactivity measured by TOPflash assays and organoid growth curves ...
-
bioRxiv - Cell Biology 2023Quote: ... and 1 ng/ml IL-3 (R&D Systems) to induce cell proliferation ...
-
bioRxiv - Physiology 2022Quote: ... Dectin-2 (1:100, clone 17611; R&D Systems), TLR2 (1:200 ...
-
bioRxiv - Cancer Biology 2021Quote: ... culture media were changed to serum free media or serum free media with 2 ug/ml IGF2 antibody (AF-292, R&D Systems) for another 72 hours ...
-
bioRxiv - Cell Biology 2022Quote: ... Noggin (100 ng mL-1, R&D Systems), and R-spondin-1 (0.5 μg mL-1 ...
-
THE OLFACTORY RECEPTOR Olfr78 REGULATES DIFFERENTIATION OF ENTEROCHROMAFFIN CELLS IN THE MOUSE COLONbioRxiv - Cell Biology 2023Quote: ... 100 ng/ml Rspondin 1 (R&D systems), 100 ng/ml noggin (both from Peprotech) ...
-
bioRxiv - Immunology 2023Quote: ... Noggin (100 ng ml−1) (R&D system) and R-Spondin (500 ng ml−1 ...
-
The transcription factor RUNX2 drives the generation of human NK cells and promotes tissue residencybioRxiv - Immunology 2022Quote: ... FMS-like tyrosine kinase-3 ligand (FLT3-L) (100 ng/mL, R&D systems) and thrombopoietin (TPO ...
-
bioRxiv - Immunology 2022Quote: ... in the presence of IL-2 (100 U/ml, R&D Systems) and IL-7 (50 ng/ml ...
-
bioRxiv - Cell Biology 2019Quote: ... 2 ug/ml Doxycycline and 3.34 ug/ml Puromycin, 1 × N27 supplement, and 10 ng/ml BDNF (STEMCELL, 78005) and GDNF (R&D Systems, 212-GD)) ...
-
bioRxiv - Bioengineering 2022Quote: ... 2 ng/ mL IGF-1 (R&D Systems), and 10 ng/ mL HGF (R&D Systems) ...
-
bioRxiv - Cancer Biology 2022Quote: ... and human FMS like tyrosine kinase 3 ligand (FLT3L, 100 ng/mL, R&D Systems).
-
bioRxiv - Biochemistry 2022Quote: ... 100 ng ml-1 CXCL12-α (R&D Systems) and/or 100 nM VUF11207 (Cayman Chemical ...
-
bioRxiv - Bioengineering 2023Quote: ... and 100 ng/ml DKK-1 (R&D Systems)) with 10 µM Y27632 (Sigma-Aldrich) ...
-
bioRxiv - Microbiology 2021Quote: ... 25 ng mL-1 IL-3 (203-GMP, R&D Systems), 2 mM GlutaMAX ...
-
bioRxiv - Developmental Biology 2023Quote: ... Goat anti-Runx 2 (1:100; R&D Systems AF2006-SP) and mouse anti-GM130 (1:100 ...
-
bioRxiv - Developmental Biology 2019Quote: ... After 2 days EBs were treated with 100 ng/ml Noggin (R&D Systems) and 10 mM SB431542 (Tocris ...
-
bioRxiv - Neuroscience 2022Quote: ... and 100 ng/mL OX-2 membrane glycoprotein (CD200) (R&D systems, cat.no. 27712CD050) growth factors in addition to the previously described growth factors.
-
bioRxiv - Immunology 2021Quote: ... Blocking of ACE2 was performed with 8 ug/mL anti-ACE2 (R&D systems) for 30 min at 37°C before adding stimuli ...
-
bioRxiv - Genetics 2021Quote: ... 3 ng/ml mouse IL-3 (R&D Systems) and 20% L-cell conditioned medium ...
-
bioRxiv - Bioengineering 2019Quote: hESCs were differentiated to SC-β cells as previously described9 by culturing in the following conditions in order: Stage 1: 3 d with 100 ng/ml Activin A (R&D Systems; 338-AC) and 3 μM CHIR99021 (Stemgent ...
-
bioRxiv - Bioengineering 2021Quote: ... 100 ng/mL human Fms-related tyrosine kinase 3 ligand (Flt3L, #308-FK, all R&D Systems), 2 mM L-GlutaMAX (Gibco #35050-038) ...
-
bioRxiv - Immunology 2023Quote: ... were coated with human ICAM-1 (3 μg/mL; R&D system) overnight at 4°C ...
-
Apical expansion of calvarial osteoblasts and suture patency is dependent on graded fibronectin cuesbioRxiv - Developmental Biology 2023Quote: ... Goat anti-Runx 2 (1:100; R&D Systems AF2006-SP; RRID:AB_2184528) and mouse anti-GM130 (1:100 ...